NCT00423358

Brief Summary

This study recruits individuals with rheumatoid arthritis (RA) and low vitamin D concentrations. Subjects are dosed with vitamin D or placebo for one year. Primary outcome is change in bone turnover markers, additionally, bone mineral density and parameters of RA status are evaluated throughout the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Feb 2005

Typical duration for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2005

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 18, 2007

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2009

Completed
6.6 years until next milestone

Results Posted

Study results publicly available

August 24, 2015

Completed
Last Updated

August 24, 2015

Status Verified

July 1, 2015

Enrollment Period

3.5 years

First QC Date

January 17, 2007

Results QC Date

May 29, 2015

Last Update Submit

July 27, 2015

Conditions

Keywords

rheumatoid arthritishypovitaminosis Dbone turnoverergocalciferol

Outcome Measures

Primary Outcomes (1)

  • Parathyroid Hormone Level

    Serum parathyroid hormone level

    1 Year

Secondary Outcomes (2)

  • Bone Mineral Density

    1 Year

  • Short Form 36 Survey

    1 Year

Study Arms (2)

vitamin D

ACTIVE COMPARATOR

ergocalciferol 50,000 IU Twice monthly

Dietary Supplement: Vitamin D

placebo

PLACEBO COMPARATOR

matching placebo tablet

Dietary Supplement: placebo

Interventions

Vitamin DDIETARY_SUPPLEMENT

Ergocalciferol 50,000 IU loading dose then twice monthly for one year

Also known as: ergocalciferol
vitamin D
placeboDIETARY_SUPPLEMENT

matching placebo

placebo

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Rheumatology

You may not qualify if:

  • Bisphosphonate therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin

Madison, Wisconsin, 53705, United States

Location

Related Publications (2)

  • Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Engelke JA, Shafer MM. Vitamin D insufficiency: disease or no disease? J Bone Miner Res. 2008 Jul;23(7):1052-60. doi: 10.1359/jbmr.080230.

  • Hansen KE, Bartels CM, Gangnon RE, Jones AN, Gogineni J. An evaluation of high-dose vitamin D for rheumatoid arthritis. J Clin Rheumatol. 2014 Mar;20(2):112-4. doi: 10.1097/RHU.0000000000000072. No abstract available.

MeSH Terms

Conditions

Arthritis, RheumatoidVitamin D Deficiency

Interventions

Vitamin DErgocalciferols

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic CompoundsCholestenesCholestanesSterolsMembrane LipidsLipids

Results Point of Contact

Title
Karen E Hansen, MD, MS
Organization
University of Wisconsin

Study Officials

  • Karen E Hansen, MD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2007

First Posted

January 18, 2007

Study Start

February 1, 2005

Primary Completion

August 1, 2008

Study Completion

February 1, 2009

Last Updated

August 24, 2015

Results First Posted

August 24, 2015

Record last verified: 2015-07

Locations